James G. Carlisle, MD, FSIR

James G. Carlisle, MD, FSIR is an interventional radiologist and the Medical Director at Wasatch Vascular Care in Salt Lake City, Utah. Dr. Carlisle graduated from the University of Michigan, where he completed his degree in Cellular and Molecular Biology with High Distinction. He was chosen by his peers to be their representative at Commencement and gave the Commencement Address. He completed a residency in diagnostic radiology at Oakwood Hospital in Dearborn, Michigan, and was chosen to be the Chief Resident.

He was selected to the prestigious interventional radiology fellowship at The Western Pennsylvania Hospital in Pittsburgh, Pennsylvania under Gordon McLean, MD, one of the most influential leaders in the field. Dr. Carlisle is board certified in diagnostic radiology with a Certificate of Added Qualification in Vascular and Interventional Radiology from the American Board of Radiology.

After a brief period with a small private group in Ohio, he transitioned to Akron, where he joined a busy practice and became an Associate Professor at Northeast Ohio Medical University’s College of Medicine.

In 2004, Dr. Carlisle and his family moved to Salt Lake City and he joined the University of Utah and Huntsman Cancer Institute as an Assistant Professor, Section Chief of Interventional Radiology, fellowship program director, and Director of the Hereditary Hemorrhagic Telangiectasia Center of Excellence. There he developed and led the establishment of the first interventional oncology clinical team in the intermountain west and the first intravascular brachytherapy (Y90) treatment center for the treatment of primary liver tumors, colorectal cancer, and other metastases to the liver. He performed the first Diomed laser alation of the greater saphenous vein in Utah, has been named on various grants and peer-reviewed publications, and enjoyed teaching medical students, residents, and fellows.

His dedicated efforts in biomedical research and clinical trials began in 2008, when he was brought to the Huntsman Cancer Institute, where he became the primary investigator on a clinical trial investigating stage 1A lung cancer. He has also served as the primary investigator on seven of the most important interventional oncology trials in the United States, focusing on colon cancer, primary liver cancer, and the treatment of painful spine metastases. He established the first oncology clinical trials team with the MountainStar system of hospitals. In 2012, he received the physician "Health Care Hero" award from Utah Business Magazine and the MountainStar Health System.

James G. Carlisle, MD, FSIR is a nationally recognized interventional oncologist specializing in minimally invasive image guided procedures for lung, kidney, colon, liver, GI, and spine cancers, as well as the treatment of arterial and venous vascular diseases. He continues to enjoy teaching physicians and is an active consultant to Dfine, BTG, Perseon Medical, and Merit Medical Systems.